Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Sep 25, 2013 brown michael s Director Option Execute 5,000 33.42
Sep 26, 2013 brown michael s Director Option Execute 5,000 33.42
Feb 26, 2014 brown michael s Director Option Execute 1,000 57.11
Mar 17, 2014 brown michael s Director Option Execute 2,000 33.42
Feb 20, 2015 brown michael s Director Option Execute 1,000 57.11
Oct 24, 2014 brown michael s Director Option Execute 5,000 57.11
Aug 15, 2014 brown michael s Director Option Execute 3,000 33.42
May 15, 2015 brown michael s Director Option Execute 5,000 57.11
Sep 21, 2015 brown michael s Director Option Execute 3,000 57.11
Dec 10, 2015 brown michael s Director Option Execute 3,000 177.82
Jan 17, 2008 brown michael s Director Automatic Sell 200 25.00
Jan 22, 2008 brown michael s Director Automatic Sell 9,800 25.00
Nov 6, 2007 brown michael s Director Automatic Sell 6,108 19.42 - 20.08
Nov 5, 2007 brown michael s Director Option Execute 10,000 7.91
Nov 2, 2009 brown michael s Director Disposition (Non Open Market) 12,000 n/a
Apr 9, 2010 brown michael s Director Acquisition (Non Open Market) 29,662 n/a
May 15, 2015 brown michael s Director Automatic Sell 5,000 495.00
Nov 5, 2007 brown michael s Director Automatic Sell 13,292 20.31 - 20.66
Nov 5, 2007 brown michael s Director Automatic Sell 600 20.67 - 20.87
Nov 5, 2015 brown michael s Director Disposition (Non Open Market) 1,000 n/a
Showing 101-120 of 1029 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)